Select Committee · Health and Social Care Committee

Pharmacy

Status: Closed Opened: 8 Jun 2023 Closed: 30 May 2024 20 recommendations 10 conclusions 1 report

The pharmacy inquiry will explore issues impacting different types of pharmacy, with a particular focus on community, primary care and hospital pharmacy services. During a time of change and reorganisation across the health and care system, and following upheaval driven by the Covid-19 pandemic, the inquiry will assess the current status of pharmacy in England … Show more

Clear

Reports

1 report
Title HC No. Published Items Response
Third Report - Pharmacy HC 140 29 May 2024 30 Responded

Recommendations & Conclusions

8 items
20 Recommendation Third Report - Pharmacy Accepted in Part

Provide free over-the-counter medication for low-income patients through Pharmacy First scheme.

To avoid patients continuing to use GPs for support that could be offered in a community pharmacy setting because of concerns about the affordability of over-the- counter medication, we recommend that such medication is free for people on low incomes, as part of the Pharmacy First scheme. Read more

Government response AI summary
The government partially accepts, clarifying that prescription-only medications supplied via Pharmacy First are free for those with existing exemptions. However, they refer to a 2018 report which concluded that providing over-the-counter medication free of charge would not offer value for money.
Read full response →
Department of Health and Social Care
21 Recommendation Third Report - Pharmacy Accepted in Part

Require Government to detail progress on Pharmacy First digital product rollout and interoperability.

When responding to this report, we ask that the Government sets out what progress has been made on rolling out the full digital product for the documentation of Pharmacy First consultations, including the percentage of community pharmacies that have fully functioning and interoperable read/write access to patient records. Read more

Government response AI summary
The government accepts the recommendation to provide progress updates on Pharmacy First digital capabilities, detailing rollout percentages and timelines for electronic referrals and record updates. However, it explicitly rejects enabling full read/write access to patient records for community pharmacies due to NHS England policy.
Read full response →
Department of Health and Social Care
23 Recommendation Third Report - Pharmacy Accepted in Part

Strategic oversight lacking for widespread adoption of automation in hospital medicines management.

There are clearly benefits to be found from using automation and technology particularly within hospital medicines management. These benefits could unlock gains in productivity, improve patient safety and free up pharmacist time to work more directly with patients. There are pockets of excellent practice across the NHS, but, outside of … Read more

Government response AI summary
The government will consider the recommendation for a more strategic view for how medicines are managed in hospitals as part of the development of the 10 Year Health Plan and how this can be applied to Trusts across England.
Read full response →
Department of Health and Social Care
24 Recommendation Third Report - Pharmacy Accepted in Part

Commission independent review into hospital medicines management, focusing on automation and digital systems.

We recommend that an independent review is commissioned to explore hospital medicines management, to report within one year. The review should make recommendations, particularly around how the potential of automation and technological systems like connected medication management could be realised and how learning from Global Digital Exemplars can be built … Read more

Government response AI summary
The government partially accepts the recommendation, committing to explore opportunities for technology use and consider the recommendation as part of developing a 10-Year Health Plan objective, rather than commissioning an independent review within one year.
Read full response →
Department of Health and Social Care
25 Conclusion Third Report - Pharmacy Accepted in Part

Insufficient placements and financial support threaten NHS Long Term Pharmacy Workforce Plan targets.

The lack of access to placements, supervisors and adequate financial support is a serious challenge, which could undermine efforts to meet the pharmacy targets set out in the NHS Long Term Workforce Plan. If those ambitions are to be met, there needs to be a greater focus on the availability … Read more

Government response AI summary
The government partially accepts, committing to publish a refreshed Long Term Workforce Plan this summer and detailing ongoing funding from NHS England to expand supervisor capacity. They also note MPharm students' eligibility for clinical tariff since 2021 and are exploring a consistent policy for placement …
Read full response →
Department of Health and Social Care
26 Recommendation Third Report - Pharmacy Accepted in Part

Update Learning Support Fund eligibility to include pharmacists and pharmacy technicians.

We recommend that the list of healthcare professionals able to access the Learning Support Fund is updated to include pharmacists and technicians. (Paragraph 140) Pharmacy 47

Government response AI summary
The government partially accepts, explaining that MPharm students are currently outside the Learning Support Fund's scope due to prior reforms. They commit to consider eligible professions for the fund as part of the refreshed Long Term Workforce Plan and are exploring a consistent policy for …
Read full response →
Department of Health and Social Care
27 Recommendation Third Report - Pharmacy Accepted in Part

Review ARRS funding criteria within three months to retain community pharmacists.

The criteria connected to Additional Roles Reimbursement Scheme (ARRS) funding should be reviewed within 3 months to understand whether any additional flexibility could reduce the drain of community pharmacists into primary care networks. The Government should write to us with the outcome of this review. Read more

Government response AI summary
The government partially accepts, stating that the Additional Roles Reimbursement Scheme funding is currently under review as part of the consultation on 2025/26 GP contract arrangements, with final details to be published after conclusion.
Read full response →
Department of Health and Social Care
29 Recommendation Third Report - Pharmacy Accepted in Part

Develop and publish an integrated, funded pharmacy workforce plan before Parliament within 12 months.

We reiterate that an integrated and funded workforce plan for pharmacy must be developed and laid before Parliament within 12 months. This should focus upon delivery of the targets set out in the NHS Long Term Workforce Plan. The pharmacy specific plan must: a) ensure that all pharmacists have adequate … Read more

Government response AI summary
The government partially accepts the recommendation, stating it will publish a refreshed Long Term Workforce Plan and is committed to growing the pharmacy workforce. NHS England is implementing strategies for independent prescribers, piloting services, and developing a 5-year pharmacy technician development programme.
Read full response →
Department of Health and Social Care

Oral evidence sessions

4 sessions
Date Witnesses
26 Mar 2024 David Webb · NHS England, Dr Amanda Doyle OBE · NHS England, Rt Hon Dame Andrea Leadsom MP · Department of Health and Social Care View ↗
19 Feb 2024 Dr Rick Greville · The Association of the British Pharmaceutical Industry (ABPI), Helen Kirrane · Diabetes UK, Janet Morrison · Community Pharmacy England, Mark Samuels · British Generic Manufacturers Association (BGMA), Mike Dent · Community Pharmacy England View ↗
16 Jan 2024 Deborah Evans · Remedi Health, Duncan Rudkin · General Pharmaceutical Council, Mark Koziol · The Pharmacists' Defence Association, Nicola Stockmann · Association of Pharmacy Technicians UK, William Pett · Healthwatch England View ↗
21 Nov 2023 Dr Graham Stretch · Primary Care Pharmacy Association, Dr James Davies · Royal Pharmaceutical Society, Dr Leyla Hannbeck · Association of Independent Multiple Pharmacies, Jay Badenhorst · National Pharmacy Association, Malcolm Harrison · Company Chemists' Association View ↗

Who gave evidence

18 witnesses
WitnessOrganisationSessions
David Webb · Chief Pharmaceutical Officer for England NHS England 1
Deborah Evans · Clinic Director and Superintendent Pharmacist Remedi Health 1
Dr Amanda Doyle OBE · National Director for Primary Care and Community … NHS England 1
Dr Graham Stretch · President Primary Care Pharmacy Association 1
Dr James Davies · Director for England Royal Pharmaceutical Society 1
Dr Leyla Hannbeck · Chief Executive Association of Independent Multiple Pharmacies 1
Dr Rick Greville · Director, Distribution and Supply The Association of the British Pharmaceutical Industry (ABPI) 1
Duncan Rudkin · Chief Executive and Registrar General Pharmaceutical Council 1
Helen Kirrane · Head of Policy, Campaigns and Mobilisation Diabetes UK 1
Janet Morrison · Chief Executive Community Pharmacy England 1
Jay Badenhorst · Vice Chair National Pharmacy Association 1
Malcolm Harrison · Chief Executive Company Chemists' Association 1
Mark Koziol · Chair The Pharmacists' Defence Association 1
Mark Samuels · CEO British Generic Manufacturers Association (BGMA) 1
Mike Dent · Director of Pharmacy Funding Community Pharmacy England 1
Nicola Stockmann · Vice President Association of Pharmacy Technicians UK 1
Rt Hon Dame Andrea Leadsom MP · Parliamentary Under-Secretary of State (Minister … Department of Health and Social Care 1
William Pett · Head of Policy, Public Affairs & Research Healthwatch England 1